Within3 in PharmaTimes: What role for virtual engagement in 2022?
Changes to work practices forced by the pandemic have highlighted the necessity – and benefits – of digital approaches for widening contacts and improving trials.
Within3 in MedCityNews: Digital collaboration here to stay for Pfizer, Merck, others
A survey found that a majority of medical affairs thought leaders see asynchronous virtual options in conjunction with in-person as the preferred path moving forward.
Within3 in Journal of mHealth: Virtual engagement builds trust for CROs and sponsors
Trust between clinical research organizations and sponsors is essential for running successful clinical trials.
Survey indicates a seismic shift in engagement, insight generation for medical affairs
Medical affairs professionals expect more virtual engagement, but need solutions that deliver higher levels of interaction and less video fatigue.
Within3 in Outsourcing Pharma: Trial tech can strengthen human connections
High-tech tools have long been part of the clinical trial process, but when they’re absent or used improperly, patient engagement can suffer.
Within3 in Journal of mHealth: How Med Tech Improves the Public Image of Pharma
Pharma success is dependent on the trust of the public, patients, and trial participants. Tech can help companies maintain a positive image and constituent trust.
Within3 on the MAPS Elevate Podcast
What is the insight gap, and why should you care? Within3’s Lance Hill and Mike Abbadessa discuss how life science companies could be missing out on important insight.
Within3 CEO Lance Hill on insights management in PharmaTimes
How insight gaps contribute to spiraling costs and long timelines – and how an insights management platform solves the problem.
Within3 Reimagines Life Science Communications to Address Insight Gaps with Industry-first, Holistic Platform
Within3 Select, Connect, and Discover follow strategic path creating the Insights Management Platform
Within3 on the Curtis & Coulter Podcast
Experts discuss the need for virtual and hybrid engagement now that in-person meetings and live events for the medical device industry are coming back.
